FMRFamide-related neuropeptides precursor protein in Sepia officinalis. This 331 amino acid precursor is proteolytically processed into at least 11 bioactive FMRFamide tetrapeptides plus three additional FaRP variants (FIRF-amide, FLRF-amide, ALSGDAFLRF-amide). The mature peptides function as excitatory neurotransmitters at the chromatophore neuromuscular junction, where they act as slow-onset, long-lasting excitors of chromatophore muscles to produce chromatophore expansion. FaRPs are expressed in the posterior chromatophore lobes of the brain and in peripheral nerves around chromatophores, consistent with their role in body patterning and pigmentation control in cephalopods.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0005576
extracellular region
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: The extracellular region annotation is based on UniProtKB subcellular location mapping. UniProt annotates this protein as "Secreted" based on experimental evidence from PMID:10805923. The mature FMRFamide peptides are released from neurons into the extracellular space at the chromatophore neuromuscular junction, where they act directly on chromatophore muscles (PMID:10805923, PMID:9319020). This is an appropriate cellular component annotation.
Reason: The protein is a secreted neuropeptide precursor. After signal peptide cleavage and proteolytic processing, the bioactive peptides are released into the extracellular space at synapses. UniProt annotates this as "Secreted" with experimental evidence from PMID:10805923. The IEA mapping from the subcellular location annotation is correct.
Supporting Evidence:
PMID:10805923
Evidence is also presented suggesting that FMRFamide-related peptides (FaRPs) also function as neurotransmitters at the Sepia chromatophore NMJ. FMRFamide application causes contraction of chromatophore muscles
PMID:9319020
FMRFamide-like immunoreactivity was also seen in the periphery, in the nerves around the chromatophores and in close apposition to the muscles in the chromatophore layer of the fin.
|
|
GO:0007218
neuropeptide signaling pathway
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: The neuropeptide signaling pathway annotation is derived from InterPro2GO mapping via the FMRFamide-related peptide domain (IPR002544). This is well supported by the literature: the FMRFa precursor encodes multiple neuropeptides that function in peptidergic signaling at the chromatophore neuromuscular junction (PMID:9192498, PMID:9319020, PMID:10805923).
Reason: This is the core biological process for this gene product. The FMRFa precursor is processed into multiple bioactive neuropeptides that function in neuropeptide signaling at the chromatophore NMJ. All four classes of FaRPs encoded by this precursor (FMRF, FLRF, FIRF, ALSGDAFLRF) cause chromatophore expansion when assayed in bioassays (PMID:9192498). The InterPro2GO mapping is appropriate and well supported.
Supporting Evidence:
PMID:9192498
Each of the four FaRPs encoded by this cDNA causes chromatophore expansion when assayed in an in vitro chromatophore bioassay. Thus, it is likely that one or more of the FaRPs identified in this study are involved in controlling chromatophore activity in cuttlefish.
PMID:9319020
We present data demonstrating that the chromatophore muscles in the European cuttlefish Sepia officinalis are also regulated by the FMRFamide family of neuropeptides. Using an in vitro chromatophore bioassay, it has been determined that several FMRFamide-related peptides (FaRPs) are potent excitors of the chromatophore muscles, causing chromatophore expansion.
|
|
GO:0160041
neuropeptide activity
|
IDA
PMID:9192498 Molecular analysis of FMRFamide- and FMRFamide-related pepti... |
NEW |
Summary: NEW annotation. The mature FMRFamide peptides function as neuropeptide ligands that activate receptors on chromatophore muscles. GO:0160041 (neuropeptide activity) is defined as "the receptor ligand activity of any polypeptide expressed in, and secreted from a neuron." FMRFa gene products are expressed in chromatophore motoneurons in the posterior chromatophore lobe and act directly on chromatophore muscles as excitatory neurotransmitters (PMID:10805923, PMID:9192498, PMID:9319020).
Reason: This is the most appropriate molecular function term for this gene product. The FMRFamide peptides are neuropeptides secreted from neurons that act as receptor ligands on target muscle cells. This is directly supported by bioassay data showing chromatophore muscle excitation (PMID:9192498), pharmacological evidence of direct action on muscle receptors (PMID:10805923), and immunocytochemical localization in neurons (PMID:10805923, PMID:9319020).
Supporting Evidence:
PMID:10805923
FMRFamide application causes contraction of chromatophore muscles; however, the FMRFamide effect is slower and longer lasting than that of glutamate. Pharmacological data show that FMRFamide acts directly on the chromatophore muscles.
PMID:9192498
The cDNA encodes a precursor protein containing four FaRPs: ALSGDAFLRF, FIRF, FLRF and FMRF.
|
|
GO:0007268
chemical synaptic transmission
|
IDA
PMID:10805923 Roles of glutamate and FMRFamide-related peptides at the chr... |
NEW |
Summary: NEW annotation. FMRFamide peptides function as neurotransmitters at the chromatophore neuromuscular junction. Loi and Tublitz (2000) demonstrated that FaRPs function as slow transmitters at the chromatophore NMJ, acting alongside glutamate (the fast transmitter). FMRFamide-immunopositive neurons are found in the posterior chromatophore lobe, and some chromatophore motoneurons co-express both FaRP-like immunoreactivity and an FaRP-coding mRNA transcript.
Reason: Chemical synaptic transmission is directly supported by multiple lines of evidence: (1) FaRPs cause chromatophore muscle contraction when applied exogenously (PMID:9319020, PMID:10805923); (2) pharmacological data show direct action on chromatophore muscles (PMID:10805923); (3) FMRFamide-immunopositive cells are present in the posterior chromatophore lobe where chromatophore motoneuron somata are located (PMID:10805923); (4) in situ hybridization confirms FaRP mRNA in putative chromatophore motoneurons (PMID:10805923). The peptides function as the slow component of dual neurotransmitter signaling at this synapse.
Supporting Evidence:
PMID:10805923
A combination of immunocytochemistry and in situ hybridization shows that some putative chromatophore motoneurons express FaRP-like immunoreactivity and an FaRP-coding mRNA transcript. Many FMRFamide-immunopositive cells in the posterior chromatophore lobes also express glutamate-like immunoreactivity. We conclude that glutamate and FaRPs likely function as fast and slow transmitters, respectively, at the Sepia chromatophore NMJ.
PMID:9319020
Immunocytochemical analyses of the central nervous system using an FMRFamide antibody revealed the presence of FMRFamide-like immunoreactive cell bodies in the posterior chromatophore lobes, the region of the brain containing the chromatophore motoneurons of the fin and mantle.
|
|
GO:0045933
positive regulation of muscle contraction
|
IDA
PMID:9319020 Peptidergic regulation of chromatophore function in the Euro... |
NEW |
Summary: NEW annotation. FMRFamide peptides are excitatory neurotransmitters that cause contraction of chromatophore muscles, resulting in chromatophore expansion. All four FaRP classes (FMRF, FLRF, FIRF, ALSGDAFLRF) were shown to be potent excitors of chromatophore muscles in in vitro bioassays (PMID:9319020, PMID:9192498). FMRFamide acts directly on the chromatophore muscles (PMID:10805923).
Reason: This annotation captures the direct excitatory effect of FMRFamide peptides on chromatophore muscle contraction. The bioassay data from multiple publications consistently show that FaRPs cause chromatophore muscle contraction (leading to chromatophore expansion). This is a core function of the FMRFa gene product in Sepia officinalis. Note the unique biology: chromatophore expansion occurs via muscle contraction (the muscles radially pull the chromatophore sac open).
Supporting Evidence:
PMID:9319020
Using an in vitro chromatophore bioassay, it has been determined that several FMRFamide-related peptides (FaRPs) are potent excitors of the chromatophore muscles, causing chromatophore expansion.
PMID:10805923
FMRFamide application causes contraction of chromatophore muscles; however, the FMRFamide effect is slower and longer lasting than that of glutamate. Pharmacological data show that FMRFamide acts directly on the chromatophore muscles.
PMID:9192498
Each of the four FaRPs encoded by this cDNA causes chromatophore expansion when assayed in an in vitro chromatophore bioassay.
|
|
GO:0043473
pigmentation
|
IDA
PMID:9319020 Peptidergic regulation of chromatophore function in the Euro... |
NEW |
Summary: NEW annotation. FMRFamide peptides regulate chromatophore expansion, which is the mechanism underlying body patterning and pigmentation in cephalopods. The FaRPs control chromatophore activity by directly activating chromatophore muscles, causing the pigment-filled sac to expand and display color (PMID:9319020, PMID:9192498). The SOFaRP2 gene is expressed in brain regions involved in chromatophore regulation (PMID:23465584).
Reason: Pigmentation in cephalopods is achieved through chromatophore organ expansion/retraction, which is under neural control. FMRFamide peptides are excitatory neurotransmitters at the chromatophore NMJ that cause chromatophore expansion (color display). While the FMRFamide peptides do not regulate pigment synthesis, they regulate the display of pigment through chromatophore expansion, which is part of the pigmentation process in the broader sense.
Supporting Evidence:
PMID:9319020
these data suggest that the FaRPs are likely to be endogenous excitors of the chromatophore muscles in cephalopods.
PMID:9192498
The display of complex color patterns of the cuttlefish Sepia officinalis is under the regulation of the FMRFamide-related peptide (FaRP) family.
|
Q: What are the specific receptors for FMRFamide peptides on Sepia chromatophore muscles? Identifying the receptor(s) would enable more precise annotation of the signaling pathway and could clarify whether FMRFamide acts via ionotropic or metabotropic mechanisms.
Q: Do different FaRP variants (FMRF vs FLRF vs FIRF vs ALSGDAFLRF) have distinct potencies or receptor specificities at the chromatophore NMJ? The precursor encodes 14 peptides of different sequences, suggesting possible functional diversification.
Q: Are there other functional roles for FMRFa gene products beyond chromatophore regulation (e.g., cardiovascular, feeding, reproductive functions)? The broad CNS expression pattern of the related SOFaRP2 gene suggests possible pleiotropic functions.
Q: What is the relationship between the two S. officinalis FaRP genes (FMRFa/SOFaRP1 and SOFaRP2) in terms of functional redundancy or specialization at the chromatophore NMJ?
Experiment: Dose-response curves comparing the four FaRP variants (FMRFamide, FLRFamide, FIRFamide, ALSGDAFLRFamide) for chromatophore expansion potency in the in vitro bioassay, to determine whether different peptides from the same precursor have distinct efficacies.
Hypothesis: Different FaRP variants encoded by the same precursor may have distinct potencies at the chromatophore NMJ, reflecting functional specialization within the peptide family.
Experiment: In vivo gene knockdown (e.g., morpholino injection into embryos) of FMRFa to assess effects on body patterning behavior and chromatophore function in developing cuttlefish.
Hypothesis: Loss of FMRFa expression will impair chromatophore-mediated body patterning behavior, confirming the essential role of FaRPs in this process.
Experiment: Electrophysiological recording of chromatophore muscle responses to individual FaRP peptides to characterize the receptor pharmacology and ion channel mechanisms underlying FMRFamide excitation at the chromatophore NMJ.
Hypothesis: FMRFamide peptides activate specific receptors on chromatophore muscles that produce slow depolarizing currents, distinct from the fast glutamate-mediated response.
provider: openai
model: o3-deep-research-2025-06-26
cached: false
start_time: '2026-05-01T14:00:28.168697'
end_time: '2026-05-01T14:05:45.418957'
duration_seconds: 317.25
template_file: templates/gene_research_go_focused.md
template_variables:
organism: SEPOF
gene_id: FMRFa
gene_symbol: FMRFa
uniprot_accession: P91889
protein_description: 'RecName: Full=FMRFamide-related neuropeptides {ECO:0000303|PubMed:11060217,
ECO:0000303|PubMed:9192498, ECO:0000312|EMBL:CAA72116.1}; Contains: RecName: Full=FIRF-amide
{ECO:0000303|PubMed:11060217, ECO:0000303|PubMed:9192498}; Contains: RecName:
Full=ALSGDAFLRF-amide {ECO:0000303|PubMed:11060217, ECO:0000303|PubMed:9192498};
Contains: RecName: Full=FLRF-amide {ECO:0000303|PubMed:11060217, ECO:0000303|PubMed:9192498};
Contains: RecName: Full=FMRF-amide 1 {ECO:0000303|PubMed:11060217, ECO:0000303|PubMed:9192498};
Contains: RecName: Full=FMRF-amide 2 {ECO:0000303|PubMed:11060217, ECO:0000303|PubMed:9192498};
Contains: RecName: Full=FMRF-amide 3 {ECO:0000303|PubMed:11060217, ECO:0000303|PubMed:9192498};
Contains: RecName: Full=FMRF-amide 4 {ECO:0000303|PubMed:11060217, ECO:0000303|PubMed:9192498};
Contains: RecName: Full=FMRF-amide 5 {ECO:0000303|PubMed:11060217, ECO:0000303|PubMed:9192498};
Contains: RecName: Full=FMRF-amide 6 {ECO:0000303|PubMed:11060217, ECO:0000303|PubMed:9192498};
Contains: RecName: Full=FMRF-amide 7 {ECO:0000303|PubMed:11060217, ECO:0000303|PubMed:9192498};
Contains: RecName: Full=FMRF-amide 8 {ECO:0000303|PubMed:11060217, ECO:0000303|PubMed:9192498};
Contains: RecName: Full=FMRF-amide 9 {ECO:0000303|PubMed:11060217, ECO:0000303|PubMed:9192498};
Contains: RecName: Full=FMRF-amide 10 {ECO:0000303|PubMed:11060217, ECO:0000303|PubMed:9192498};
Contains: RecName: Full=FMRF-amide 11 {ECO:0000303|PubMed:11060217, ECO:0000303|PubMed:9192498};
Flags: Precursor;'
gene_info: Name=FMRFa {ECO:0000303|PubMed:11060217};
organism_full: Sepia officinalis (Common cuttlefish).
protein_family: Belongs to the FARP (FMRFamide related peptide) family.
protein_domains: FMRFamid-related_peptide-like. (IPR002544); FMRFamide-related_np.
(IPR051041); FARP (PF01581)
provider_config:
timeout: 600
max_retries: 3
parameters:
allowed_domains: []
temperature: 0.1
top_p: 1.0
citation_count: 74
BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.
DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'FMRFa' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information
Please provide a comprehensive research report on the gene FMRFa (gene ID: FMRFa, UniProt: P91889) in SEPOF.
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
FMRFa in Sepia officinalis encodes a precursor protein that is processed into multiple FMRFamide-related peptides (FaRPs). FMRFamide (Phe-Met-Arg-Phe-NH₂) is a hallmark tetrapeptide neuropeptide originally discovered in mollusks in 1977 (www.frontiersin.org). The S. officinalis FMRFa gene belongs to the FaRP peptide family (UniProt P91889) and produces a ~331 amino acid precursor (~39 kDa) containing an N-terminal signal peptide and numerous repeated neuropeptide sequences (pmc.ncbi.nlm.nih.gov). Proteolytic processing of this precursor yields at least four distinct neuropeptides, including single copies of FLRFamide, ALSGDAFLRFamide, FIRFamide, and multiple copies (∼11 repeats in cuttlefish) of FMRFamide itself (pmc.ncbi.nlm.nih.gov) (www.sciencedirect.com). A conserved furin cleavage site (RX[K/R]R) separates the precursor into regions, facilitating the liberation of the active C-terminal RFamide peptides (www.frontiersin.org). These peptides all share the C-terminal –RFamide motif, characteristic of this neuropeptide family.
Conservation and Family – FMRFamide and related RFamide peptides are evolutionarily widespread. Since its initial characterization as a cardio-excitatory neuropeptide in clams, RFamide peptides have been identified across diverse phyla – from cnidarians to arthropods and chordates (pmc.ncbi.nlm.nih.gov). In mollusks, the FMRFa gene is one of five major RFamide precursor genes, alongside LFRFamide, luqin, neuropeptide F, and others (www.frontiersin.org). Notably, insects like Drosophila also possess an FMRFamide gene (sometimes denoted FMRFa), encoding similar neuropeptides – underscoring the conserved role of RFamide signaling in invertebrate nervous systems. (This report focuses on the S. officinalis FMRFa; care is taken not to confuse it with homologs in other species.)
Cellular Localization: The FMRFa precursor contains a signal peptide directing it into the secretory pathway (pmc.ncbi.nlm.nih.gov). It is packaged in neurosecretory vesicles and cleaved into active peptides that are secreted as neurotransmitters or neurohormones. Thus, the mature peptides function extracellularly, binding to receptors on target cells. Within neurons, FMRFamide peptides are often localized to dense-core vesicles in synapses or neurohemal release sites.
Tissue Distribution: Expression of FMRFa is highly central nervous system (CNS)-enriched. A 2018 analysis in a related cuttlefish (Sepiella japonica) showed highest FMRFa mRNA levels in the brain (in both sexes) compared to other tissues (pmc.ncbi.nlm.nih.gov). In S. officinalis, in situ hybridization and immunochemical studies have similarly found FMRFa transcripts and peptides widely distributed across brain lobes (pmc.ncbi.nlm.nih.gov). FMRFamide immunoreactivity is present in many neural circuits of the supraesophageal and subesophageal masses (the cephalopod brain regions) (pmc.ncbi.nlm.nih.gov). Peripheral nervous structures also contain FMRFamide-expressing neurons; for example, FMRFamide-positive fibers innervate the optic gland, viscera, and peripheral nerves (www.frontiersin.org). Notably, FMRFamide-like peptides are present in the venous blood of cephalopods, indicating neurohormonal release into circulation (www.frontiersin.org). Recent evidence even suggests expression outside the nervous system: immune cells (hemocytes) of molluscs can express and synthesize FMRFamide peptides (www.frontiersin.org). In cuttlefish and octopus, FMRFamide-expressing neurons project to endocrine glands (optic gland) and peripheral organs, underscoring a neuroendocrine role (www.frontiersin.org).
Subcellular Localization: Within neurons, the FMRFa precursor is processed in the Golgi and packaged in secretory granules. The mature peptides are stored in synaptic terminals or neurohemal areas until stimulus-triggered release. In target cells, FMRFamide receptors are membrane-bound (GPCRs or ion channels, discussed below). For instance, a specialized FMRFamide-gated Na⁺ channel cloned from S. japonica (SjFaNaC) was shown to localize to the cell surface when expressed in HEK293 cells (pubmed.ncbi.nlm.nih.gov), consistent with it being an extracellular ligand receptor.
Neuropeptide Signaling: FMRFa’s gene product is fundamentally a neurotransmitter/neuromodulator precursor. The liberated FMRFamide peptides bind to specific receptors on neurons or muscle cells to modulate their activity. These peptides are considered important neurotransmitters or neuromodulators in invertebrates, influencing a wide range of neural and physiological processes (pmc.ncbi.nlm.nih.gov).
Receptors and Pathways: Two main types of FMRFamide receptors are known in invertebrates: G protein-coupled receptors and ligand-gated ion channels. Most commonly, FMRFamide-related peptides signal through G-protein coupled receptors (GPCRs) on target cell membranes (www.sciencedirect.com). Binding of FMRFamide to its GPCR triggers intracellular second messenger cascades (e.g. via G_q or G_i pathways), ultimately altering neuronal excitability or cellular responses (www.sciencedirect.com). For example, FMRFamide receptors in mollusks are related to the neuropeptide FF receptor family and initiate signaling that modulates ion channel activity and gene expression. Sepiella cuttlefish were recently found to possess an FMRFamide GPCR (418 amino acids, seven-transmembrane structure) expressed in neural tissues (www.sciencedirect.com). This receptor (SjFaGPCR) is thought to mediate many of the peptide’s physiological effects, such as reproductive maturation signals (www.sciencedirect.com).
Unusually, FMRFamide can also act directly on ion channels. A family of FMRFamide-activated Na⁺ channels (FaNaCs) has been characterized in mollusks (pubmed.ncbi.nlm.nih.gov). These are non-voltage-gated, amiloride-sensitive sodium channels opened by FMRFamide binding, causing rapid depolarization of neurons. The S. japonica FaNaC channel (603 amino acids) is conserved in cephalopods and highly expressed in the brain and optic lobe, as well as in gonadal tissue (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). FaNaCs provide a fast, excitatory mechanism for FMRFamide signaling, complementing the slower GPCR-mediated modulation. In molluscan neurons (e.g. in snails), FMRFamide can inhibit neural activity by other means as well – for instance, by modulating ion conductances via second messengers. In Aplysia neurons, FMRFamide was shown to open K⁺ channels and reduce Ca²⁺ currents, rapidly terminating bursting activity (pubmed.ncbi.nlm.nih.gov). Thus, depending on context, FMRFamide peptides can either excite or inhibit target cells through distinct mechanisms – direct channel gating or G-protein signaling – ultimately tuning neuronal circuit activity.
1. Neuromodulation and Behavior: As a broadly expressed neuropeptide, FMRFamide influences many neural circuits and behaviors in cephalopods. Motor patterning and chromatophore control is one such role – FMRFamide-related peptides modulate the expansion of chromatophores (pigment cells) that produce dynamic skin patterns in cuttlefish (pmc.ncbi.nlm.nih.gov). Experimental studies in Sepia officinalis showed that applying FMRFamide or related peptides can alter chromatophore muscle contraction, affecting color change and body patterning (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). This indicates FMRFamide’s involvement in the neural control of camouflage and display behaviors (likely via neuromuscular modulation in the skin). More generally, FMRFamide acts within the cephalopod CNS as a neuromodulator of locomotor and sensory circuits. It is considered a “broadcast” neurotransmitter that can adjust the excitability of networks, shaping behaviors such as locomotion, feeding, or escape responses (as observed in other mollusks (pmc.ncbi.nlm.nih.gov)).
2. Cardio-Excretory and Peripheral Effects: FMRFamide’s discovery as a cardio-excitatory peptide highlights its role in modulating muscle tissues. In the clam heart, FMRFamide increases heartbeat frequency and contraction strength (www.frontiersin.org). In cuttlefish, FMRFamide-immunoreactive neurons innervate parts of the gut and blood vessels, suggesting roles in regulating visceral muscle contraction and possibly excretory organs. In one study, a novel RFamide peptide (GNLFRFamide, from a related gene) increased contraction frequency of the cuttlefish rectum at nanomolar concentrations (www.sciencedirect.com). The FMRFa gene’s peptides (like FMRFamide, FLRFamide) likely have similar myotropic effects on smooth muscles in the reproductive and digestive systems (pubmed.ncbi.nlm.nih.gov). This modulatory control ensures that physiological rhythms (heart rate, gut motility) can be adjusted by the nervous system.
3. Reproductive Function: One of the most well-documented functions of FMRFamide in cephalopods is in reproduction and egg-laying. S. officinalis uses FaRP neuropeptides to coordinate ovulation and egg casing production. Henry et al. (1999) purified FMRFamide and related peptides from female optic lobes and demonstrated their effect on oviduct contraction (pubmed.ncbi.nlm.nih.gov). The tetrapeptides FMRFamide and FLRFamide strongly stimulated oviduct muscle contractions, promoting egg transport, whereas the larger peptides FIRFamide and ALSGDAFLRFamide reduced contraction frequency and tone (pubmed.ncbi.nlm.nih.gov). This suggests a finely tuned balance: some FaRPs trigger muscular contraction to propel oocytes, while others relax the tract between egg releases. The same study found FMRFamide-positive nerve fibers innervating the accessory sex glands (nidamental glands) that secrete the egg capsule (pubmed.ncbi.nlm.nih.gov). In vitro, FMRFamide modulated contractions of the nidamental gland, likely inducing secretion of egg capsule materials during ovulation (pubmed.ncbi.nlm.nih.gov). These results show that FMRFa peptides play an integral role in synchronizing ovulation with egg encapsulation and laying in cuttlefish.
In octopuses, FMRFamide appears to have analogous reproductive roles. Octopus vulgaris expresses FMRFamide in neurons that innervate the optic gland (a neuroendocrine gland controlling sexual maturation) (pmc.ncbi.nlm.nih.gov). Di Cosmo et al. (2003) reported that FMRFamide signalling influences gonadal development and reproductive timing in octopus, possibly by modulating optic gland hormone release (pmc.ncbi.nlm.nih.gov). In Sepiella (Chinese cuttlefish), FMRFamide expression rises during sexual maturation, and experimental evidence suggests it promotes aspects of reproductive development (www.sciencedirect.com). Taken together, FMRFa neuropeptides serve as key neuroendocrine regulators of cephalopod reproduction – linking the nervous system to reproductive organ function and timing.
4. Neuroendocrine Regulation (Optic Gland): The cephalopod optic gland is functionally analogous to the vertebrate pituitary, releasing hormones that trigger sexual maturation and senescence. FMRFamide-like peptides have been found in neurons projecting to the optic gland in cuttlefish (pmc.ncbi.nlm.nih.gov) and squid, hinting at regulatory control. Early immunohistochemical work (Le Guez et al. 1988) showed FMRFamide-immunoreactive fibers densely innervating the Sepia optic gland (pmc.ncbi.nlm.nih.gov). This peptidergic innervation suggests FMRFamide could modulate the gland’s endocrine output. Indeed, applying FMRFamide in Octopus can alter optic gland activity and was linked to changes in reproductive hormone levels (pmc.ncbi.nlm.nih.gov). Thus, FMRFa peptides may act as neuroendocrine messengers, ensuring that environmental or neural cues appropriately influence hormone release for reproduction. This role fits into the broader reproductive function described above and highlights FMRFamide as a bridge between nervous and endocrine systems in cephalopods.
5. Immune System Modulation: Sepia FMRFamide is now recognized to also participate in the neuroimmune axis. A recent 2022 study demonstrated that FMRFamide has an immunoregulatory role during stress in cuttlefish (www.frontiersin.org) (www.frontiersin.org). When juvenile S. japonica were challenged with bacterial infection (Vibrio), FMRFa gene expression in neural tissues was significantly upregulated alongside nitric oxide synthase (NOS) expression (www.frontiersin.org). This co-expression led researchers to investigate FMRFamide’s effect on immune-related nitric oxide (NO) production. Strikingly, knockdown of the FMRFa precursor gene via RNA interference caused excessive NO production after immune challenge, whereas adding exogenous FMRFamide peptide suppressed NO levels (www.frontiersin.org). Whole-mount in situ hybridization showed FMRFa mRNA and NOS mRNA co-localized in certain tissues, suggesting direct interaction (www.frontiersin.org). Collectively, these results indicate that FMRFamide acts as a negative feedback regulator of inflammation, inhibiting NO synthesis to prevent overshooting cytotoxic immune responses (www.frontiersin.org). The proposed model is that during late-stage immune responses, neural FMRFamide is released to dampen macrophage or hemocyte activity, curbing nitric oxide-mediated damage (www.frontiersin.org). This discovery expands FMRFamide’s functional repertoire beyond the nervous system, identifying it as a component of cephalopod innate immune regulation (likely via neuroendocrine-immune signaling pathways). It also underscores cephalopods as “advanced” invertebrates with intricate neuroimmune communication (www.frontiersin.org).
FMRFa peptides in Sepia and other cephalopods remain an active research area, with recent studies focusing on receptor characterization and potential applications in aquaculture. Receptor Identification: In late 2023, Xie et al. cloned the first FMRFamide-specific GPCR from S. japonica, confirming the molecular target through which FMRFa neuropeptides exert many effects (www.sciencedirect.com). Similarly, the FaNaC ion channel gene was cloned in 2024, and its expression in reproductive organs hints at a role in mediating FMRFamide’s effects on gonadal maturation (pubmed.ncbi.nlm.nih.gov). Characterizing these receptors helps decipher the signal transduction pathways (e.g., which second messengers or ion currents are involved) and could reveal drug targets to modulate FMRFamide signaling.
Physiological Genomics: With the sequencing of cephalopod genomes, researchers have identified multiple FMRFamide gene variants. In Sepia officinalis, at least two distinct FaRP precursor genes exist (termed SOFaRP1 and SOFaRP2) (www.frontiersin.org). The second gene (SOFaRP2) was described in 2012 with a distinct expression pattern in the brain (www.frontiersin.org). The diversity of RFamide peptides from these genes (~75 different RFamide peptides across mollusks) and their spatial expression suggest specialized functions (www.frontiersin.org) (www.frontiersin.org). Ongoing work is examining how different RFamide peptides (e.g. the unique GNLFRFamide vs. FMRFamide) have differentiated roles, and how alternative splicing or gene duplication contributes to neural complexity in cephalopods (pmc.ncbi.nlm.nih.gov).
Aquaculture and Applied Research: Understanding FMRFa’s function has practical implications, especially for cephalopod aquaculture and biology. Cuttlefish are short-lived and semelparous (single reproductive cycle), so manipulating neuropeptide signals could influence reproduction and growth. The 2018 S. japonica study suggested that knowledge of FMRFamide regulation may aid in developing aquaculture techniques (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). For instance, if FMRFamide or its analogs can be used to synchronize or induce spawning and egg-laying, hatchery efficiency could improve. Likewise, intervening in FMRFamide signaling might modulate stress responses or immunity in captive cephalopods, improving survival. While these applications are still speculative, they stem from the recognized roles of FMRFamide in coordinating key physiological processes (reproduction, muscle contraction, immune balance). Additionally, FMRFamide is used as a research tool in neurobiology – as a known modulator, it’s applied to probe neural circuit function in mollusks. Its ability to activate FaNaC channels, for example, makes it useful for studies of ion channel gating and neuropharmacology (pubmed.ncbi.nlm.nih.gov).
Experts in neuropeptide biology consider FMRFamide and related FaRPs to be central regulators in molluscan physiology. They note that a single FMRFa precursor gene can influence an array of systems – “from chromatophore expansion and locomotion to reproduction and even immune defense” – by releasing multiple peptides that target different receptors (pmc.ncbi.nlm.nih.gov) (www.frontiersin.org). Such breadth of action is a hallmark of neuromodulators. Despite this pleiotropy, each role of FMRFamide is quite specific in context. In summary, the Sepia officinalis FMRFa gene encodes a multi-peptide neurohormone system that integrates neural, endocrine, and immune functions. Its peptides act as messengers that fine-tune muscular activity, developmental timing, and homeostatic responses, making FMRFamide a pivotal molecule for the physiology and behavior of cephalopods.
References: Recent key studies and reviews underpinning this annotation include: Henry et al., 1999 (Peptides) (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov); Di Cosmo et al., 2003 (pmc.ncbi.nlm.nih.gov); Loi & Tublitz, 1996/2006 on chromatophores (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov); Le Guez et al., 1988 on optic gland innervation (pmc.ncbi.nlm.nih.gov); Ying Li et al., 2018 (Molecules) on cuttlefish FMRFa gene characterization (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov); Zheng et al., 2022 (Front. Immunol.) on neuroimmune function (www.frontiersin.org) (www.frontiersin.org); and Xie/Li et al., 2024 (Neuropeptides) on FMRFamide receptors (www.sciencedirect.com), among others. These sources provide detailed experimental evidence of FMRFa’s structure, expression, and diverse functions across physiology. The consensus from authoritative reviews is that FMRFamide-related peptides are ubiquitous and versatile neuromodulators, underscoring the importance of the FMRFa gene in molluscan neurobiology (pmc.ncbi.nlm.nih.gov).
id: P91889
gene_symbol: FMRFa
product_type: PROTEIN
status: IN_PROGRESS
taxon:
id: NCBITaxon:6610
label: Sepia officinalis
description: >-
FMRFamide-related neuropeptides precursor protein in Sepia officinalis. This 331 amino acid
precursor is proteolytically processed into at least 11 bioactive FMRFamide tetrapeptides plus
three additional FaRP variants (FIRF-amide, FLRF-amide, ALSGDAFLRF-amide). The mature peptides
function as excitatory neurotransmitters at the chromatophore neuromuscular junction, where they
act as slow-onset, long-lasting excitors of chromatophore muscles to produce chromatophore
expansion. FaRPs are expressed in the posterior chromatophore lobes of the brain and in peripheral
nerves around chromatophores, consistent with their role in body patterning and pigmentation
control in cephalopods.
existing_annotations:
- term:
id: GO:0005576
label: extracellular region
evidence_type: IEA
original_reference_id: GO_REF:0000044
review:
summary: >-
The extracellular region annotation is based on UniProtKB subcellular location mapping.
UniProt annotates this protein as "Secreted" based on experimental evidence from
PMID:10805923. The mature FMRFamide peptides are released from neurons into the extracellular
space at the chromatophore neuromuscular junction, where they act directly on chromatophore
muscles (PMID:10805923, PMID:9319020). This is an appropriate cellular component annotation.
action: ACCEPT
reason: >-
The protein is a secreted neuropeptide precursor. After signal peptide cleavage and
proteolytic processing, the bioactive peptides are released into the extracellular space
at synapses. UniProt annotates this as "Secreted" with experimental evidence from
PMID:10805923. The IEA mapping from the subcellular location annotation is correct.
supported_by:
- reference_id: PMID:10805923
supporting_text: >-
Evidence is also presented suggesting that FMRFamide-related peptides (FaRPs) also
function as neurotransmitters at the Sepia chromatophore NMJ. FMRFamide application
causes contraction of chromatophore muscles
- reference_id: PMID:9319020
supporting_text: >-
FMRFamide-like immunoreactivity was also seen in the periphery, in the nerves around
the chromatophores and in close apposition to the muscles in the chromatophore layer of
the fin.
- term:
id: GO:0007218
label: neuropeptide signaling pathway
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: >-
The neuropeptide signaling pathway annotation is derived from InterPro2GO mapping via the
FMRFamide-related peptide domain (IPR002544). This is well supported by the literature:
the FMRFa precursor encodes multiple neuropeptides that function in peptidergic signaling
at the chromatophore neuromuscular junction (PMID:9192498, PMID:9319020, PMID:10805923).
action: ACCEPT
reason: >-
This is the core biological process for this gene product. The FMRFa precursor is processed
into multiple bioactive neuropeptides that function in neuropeptide signaling at the
chromatophore NMJ. All four classes of FaRPs encoded by this precursor (FMRF, FLRF, FIRF,
ALSGDAFLRF) cause chromatophore expansion when assayed in bioassays (PMID:9192498). The
InterPro2GO mapping is appropriate and well supported.
supported_by:
- reference_id: PMID:9192498
supporting_text: >-
Each of the four FaRPs encoded by this cDNA causes chromatophore expansion when assayed
in an in vitro chromatophore bioassay. Thus, it is likely that one or more of the FaRPs
identified in this study are involved in controlling chromatophore activity in cuttlefish.
- reference_id: PMID:9319020
supporting_text: >-
We present data demonstrating that the chromatophore muscles in the European cuttlefish
Sepia officinalis are also regulated by the FMRFamide family of neuropeptides. Using an
in vitro chromatophore bioassay, it has been determined that several FMRFamide-related
peptides (FaRPs) are potent excitors of the chromatophore muscles, causing chromatophore
expansion.
- term:
id: GO:0160041
label: neuropeptide activity
evidence_type: IDA
original_reference_id: PMID:9192498
review:
summary: >-
NEW annotation. The mature FMRFamide peptides function as neuropeptide ligands that activate
receptors on chromatophore muscles. GO:0160041 (neuropeptide activity) is defined as
"the receptor ligand activity of any polypeptide expressed in, and secreted from a neuron."
FMRFa gene products are expressed in chromatophore motoneurons in the posterior chromatophore
lobe and act directly on chromatophore muscles as excitatory neurotransmitters
(PMID:10805923, PMID:9192498, PMID:9319020).
action: NEW
reason: >-
This is the most appropriate molecular function term for this gene product. The FMRFamide
peptides are neuropeptides secreted from neurons that act as receptor ligands on target
muscle cells. This is directly supported by bioassay data showing chromatophore muscle
excitation (PMID:9192498), pharmacological evidence of direct action on muscle receptors
(PMID:10805923), and immunocytochemical localization in neurons (PMID:10805923, PMID:9319020).
supported_by:
- reference_id: PMID:10805923
supporting_text: >-
FMRFamide application causes contraction of chromatophore muscles; however, the
FMRFamide effect is slower and longer lasting than that of glutamate. Pharmacological
data show that FMRFamide acts directly on the chromatophore muscles.
- reference_id: PMID:9192498
supporting_text: >-
The cDNA encodes a precursor protein containing four FaRPs: ALSGDAFLRF, FIRF, FLRF
and FMRF.
- term:
id: GO:0007268
label: chemical synaptic transmission
evidence_type: IDA
original_reference_id: PMID:10805923
review:
summary: >-
NEW annotation. FMRFamide peptides function as neurotransmitters at the chromatophore
neuromuscular junction. Loi and Tublitz (2000) demonstrated that FaRPs function as slow
transmitters at the chromatophore NMJ, acting alongside glutamate (the fast transmitter).
FMRFamide-immunopositive neurons are found in the posterior chromatophore lobe, and some
chromatophore motoneurons co-express both FaRP-like immunoreactivity and an FaRP-coding
mRNA transcript.
action: NEW
reason: >-
Chemical synaptic transmission is directly supported by multiple lines of evidence:
(1) FaRPs cause chromatophore muscle contraction when applied exogenously (PMID:9319020,
PMID:10805923); (2) pharmacological data show direct action on chromatophore muscles
(PMID:10805923); (3) FMRFamide-immunopositive cells are present in the posterior
chromatophore lobe where chromatophore motoneuron somata are located (PMID:10805923);
(4) in situ hybridization confirms FaRP mRNA in putative chromatophore motoneurons
(PMID:10805923). The peptides function as the slow component of dual neurotransmitter
signaling at this synapse.
supported_by:
- reference_id: PMID:10805923
supporting_text: >-
A combination of immunocytochemistry and in situ hybridization shows that some putative
chromatophore motoneurons express FaRP-like immunoreactivity and an FaRP-coding mRNA
transcript. Many FMRFamide-immunopositive cells in the posterior chromatophore lobes
also express glutamate-like immunoreactivity. We conclude that glutamate and FaRPs
likely function as fast and slow transmitters, respectively, at the Sepia chromatophore
NMJ.
- reference_id: PMID:9319020
supporting_text: >-
Immunocytochemical analyses of the central nervous system using an FMRFamide antibody
revealed the presence of FMRFamide-like immunoreactive cell bodies in the posterior
chromatophore lobes, the region of the brain containing the chromatophore motoneurons
of the fin and mantle.
- term:
id: GO:0045933
label: positive regulation of muscle contraction
evidence_type: IDA
original_reference_id: PMID:9319020
review:
summary: >-
NEW annotation. FMRFamide peptides are excitatory neurotransmitters that cause contraction
of chromatophore muscles, resulting in chromatophore expansion. All four FaRP classes
(FMRF, FLRF, FIRF, ALSGDAFLRF) were shown to be potent excitors of chromatophore muscles
in in vitro bioassays (PMID:9319020, PMID:9192498). FMRFamide acts directly on the
chromatophore muscles (PMID:10805923).
action: NEW
reason: >-
This annotation captures the direct excitatory effect of FMRFamide peptides on chromatophore
muscle contraction. The bioassay data from multiple publications consistently show that
FaRPs cause chromatophore muscle contraction (leading to chromatophore expansion). This
is a core function of the FMRFa gene product in Sepia officinalis. Note the unique biology:
chromatophore expansion occurs via muscle contraction (the muscles radially pull the
chromatophore sac open).
supported_by:
- reference_id: PMID:9319020
supporting_text: >-
Using an in vitro chromatophore bioassay, it has been determined that several
FMRFamide-related peptides (FaRPs) are potent excitors of the chromatophore muscles,
causing chromatophore expansion.
- reference_id: PMID:10805923
supporting_text: >-
FMRFamide application causes contraction of chromatophore muscles; however, the
FMRFamide effect is slower and longer lasting than that of glutamate. Pharmacological
data show that FMRFamide acts directly on the chromatophore muscles.
- reference_id: PMID:9192498
supporting_text: >-
Each of the four FaRPs encoded by this cDNA causes chromatophore expansion when assayed
in an in vitro chromatophore bioassay.
- term:
id: GO:0043473
label: pigmentation
evidence_type: IDA
original_reference_id: PMID:9319020
review:
summary: >-
NEW annotation. FMRFamide peptides regulate chromatophore expansion, which is the mechanism
underlying body patterning and pigmentation in cephalopods. The FaRPs control chromatophore
activity by directly activating chromatophore muscles, causing the pigment-filled sac to
expand and display color (PMID:9319020, PMID:9192498). The SOFaRP2 gene is expressed in
brain regions involved in chromatophore regulation (PMID:23465584).
action: NEW
reason: >-
Pigmentation in cephalopods is achieved through chromatophore organ expansion/retraction,
which is under neural control. FMRFamide peptides are excitatory neurotransmitters at the
chromatophore NMJ that cause chromatophore expansion (color display). While the FMRFamide
peptides do not regulate pigment synthesis, they regulate the display of pigment through
chromatophore expansion, which is part of the pigmentation process in the broader sense.
additional_reference_ids:
- PMID:23465584
- PMID:21802466
supported_by:
- reference_id: PMID:9319020
supporting_text: >-
these data suggest that the FaRPs are likely to be endogenous excitors of the
chromatophore muscles in cephalopods.
- reference_id: PMID:9192498
supporting_text: >-
The display of complex color patterns of the cuttlefish Sepia officinalis is under
the regulation of the FMRFamide-related peptide (FaRP) family.
references:
- id: PMID:9192498
title: Molecular analysis of FMRFamide- and FMRFamide-related peptides (FaRPS) in the cuttlefish Sepia officinalis
findings:
- statement: Cloned full-length FaRP cDNA from S. officinalis brain encoding precursor protein with four FaRPs
supporting_text: >-
We report the isolation and characterization of a full-length FaRP cDNA from the brain
of S. officinalis. The cDNA encodes a precursor protein containing four FaRPs: ALSGDAFLRF,
FIRF, FLRF and FMRF.
- statement: Each FaRP propeptide flanked by basic amino acid cleavage sites and has C-terminal glycine for amidation
supporting_text: >-
Each propeptide has a C-terminal glycine residue that is presumably converted
post-translationally to an amide. Every FaRP propeptide is also flanked by basic amino
acid residues at the amino and carboxy termini, indicative of putative cleavage sites.
- statement: All four FaRPs caused chromatophore expansion in in vitro bioassay
supporting_text: >-
Each of the four FaRPs encoded by this cDNA causes chromatophore expansion when assayed
in an in vitro chromatophore bioassay.
- id: PMID:9319020
title: Peptidergic regulation of chromatophore function in the European cuttlefish Sepia officinalis
findings:
- statement: FaRPs are potent excitors of chromatophore muscles causing chromatophore expansion
supporting_text: >-
Using an in vitro chromatophore bioassay, it has been determined that several
FMRFamide-related peptides (FaRPs) are potent excitors of the chromatophore muscles,
causing chromatophore expansion.
- statement: FMRFamide-like immunoreactive cell bodies found in posterior chromatophore lobes
supporting_text: >-
Immunocytochemical analyses of the central nervous system using an FMRFamide antibody
revealed the presence of FMRFamide-like immunoreactive cell bodies in the posterior
chromatophore lobes, the region of the brain containing the chromatophore motoneurons
of the fin and mantle.
- statement: FMRFamide-like immunoreactivity in peripheral nerves in close apposition to chromatophore muscles
supporting_text: >-
FMRFamide-like immunoreactivity was also seen in the periphery, in the nerves around
the chromatophores and in close apposition to the muscles in the chromatophore layer
of the fin.
- statement: HPLC identified bioactive FMRFamide-immunoreactive peaks co-eluting with FMRFamide and ALSGDAFLRFamide
supporting_text: >-
HPLC analysis of the fin dermis isolated four bioactive peaks that were
FMRFamide-immunoreactive when tested on an immunoblot assay. Two of these peaks
co-eluted with known FaRPs, FMRFamide and ALSGDAFLRFamide.
- id: PMID:10805923
title: Roles of glutamate and FMRFamide-related peptides at the chromatophore neuromuscular junction in the cuttlefish, Sepia officinalis
findings:
- statement: FMRFamide causes chromatophore muscle contraction with slower onset and longer duration than glutamate
supporting_text: >-
FMRFamide application causes contraction of chromatophore muscles; however, the
FMRFamide effect is slower and longer lasting than that of glutamate.
- statement: Pharmacological data show FMRFamide acts directly on chromatophore muscles
supporting_text: >-
Pharmacological data show that FMRFamide acts directly on the chromatophore muscles.
- statement: In situ hybridization confirms FaRP mRNA in putative chromatophore motoneurons
supporting_text: >-
A combination of immunocytochemistry and in situ hybridization shows that some putative
chromatophore motoneurons express FaRP-like immunoreactivity and an FaRP-coding mRNA transcript.
- statement: Glutamate and FaRPs function as fast and slow transmitters at the chromatophore NMJ
supporting_text: >-
We conclude that glutamate and FaRPs likely function as fast and slow transmitters,
respectively, at the Sepia chromatophore NMJ.
- statement: Many FMRFamide-immunopositive cells co-express glutamate-like immunoreactivity
supporting_text: >-
Many FMRFamide-immunopositive cells in the posterior chromatophore lobes also express
glutamate-like immunoreactivity.
- id: PMID:11060217
title: Mass spectrometric survey of peptides in cephalopods with an emphasis on the FMRFamide-related peptides
findings:
- statement: MALDI MS confirmed presence of FMRFamide-related peptides in Sepia officinalis nerves
supporting_text: >-
A MALDI mass spectrometric survey of the major peptides in the stellar, fin and pallial
nerves and the posterior chromatophore lobe of the cephalopods Sepia officinalis, Loligo
opalescens and Dosidicus gigas has been performed.
- statement: FRPs are conserved across cephalopods
supporting_text: >-
The FRPs predicted by this gene (FMRFa, FLRFa/FIRFa and ALSGDAFLRFa) are observed in
all three species, indicating that members of this peptide family are highly conserved
across cephalopods.
- id: PMID:21802466
title: Molecular analysis of a novel FMRFamide-related peptide gene (SOFaRP2) and its expression pattern in the brain of the European cuttlefish Sepia officinalis
findings:
- statement: Second FaRP gene (SOFaRP2) cloned in S. officinalis encoding four different FaRPs
supporting_text: >-
The complete 835-base pair cDNA sequence of the SOFaRP2 gene contains an open reading
frame of 567 base pairs encoding 188 amino acids and four putative FaRPs.
- statement: SOFaRP2 expressed in brain regions involved in chromatophore regulation
supporting_text: >-
The SOFaRP2 gene appears to be expressed in all brain regions involved in chromatophore regulation.
- id: PMID:23465584
title: Expression of the SOFaRP2 gene in the central nervous system of the adult cuttlefish Sepia officinalis
findings:
- statement: SOFaRP2 most intensively expressed in posterior chromatophore lobe and vasomotor lobe
supporting_text: >-
The SOFaRP2 gene was found to be expressed most intensively in the posterior chromatophore
lobe, vasomotor lobe and subvertical lobe.
- statement: Expression pattern suggests involvement in chromatophore regulation and feeding behavior
supporting_text: >-
The expression pattern of SOFaRP2 suggests its involvement in chromatophore regulation,
feeding behavior, and learning and memory.
- id: PMID:21397478
title: FaRP cell distribution in the developing CNS suggests the involvement of FaRPs in all parts of the chromatophore control pathway in Sepia officinalis
findings:
- statement: FaRP expression detected in nervous system from beginning of organogenesis
supporting_text: >-
We detected FaRP expression and production in the nervous system of embryos from the
beginning of organogenesis (stage 16).
- statement: FaRPs involved in all parts of the neural body pattern control system
supporting_text: >-
Most of these areas were implicated in the control of body patterns, suggesting that
FaRPs are involved in all parts of the neural body pattern control system, from the
receptive areas via the CNS to the chromatophore effectors.
- id: PMID:10499423
title: >-
Peptidergic control of egg-laying in the cephalopod Sepia officinalis: involvement
of FMRFamide and FMRFamide-related peptides.
findings:
- statement: >-
FMRFamide and FLRFamide strongly stimulate oviduct muscle contraction, promoting
egg transport, while FIRFamide and ALSGDAFLRFamide reduce contraction frequency
and tone
- statement: >-
FMRFamide-positive nerve fibers innervate the nidamental glands (accessory sex
glands) that secrete the egg capsule
- statement: >-
FMRFamide modulates contractions of the nidamental gland, likely inducing
secretion of egg capsule materials during ovulation
- id: PMID:38776655
title: >-
A Na+ channel receptor of FMRFamide in the cephalopod Sepiella japonica:
Identification, characterisation, and expression profiling during different
stages of gonadal development.
findings:
- statement: >-
FMRFamide-activated Na+ channel (FaNaC) cloned from S. japonica, 603 amino
acids, highly expressed in brain, optic lobe, and gonadal tissue
- statement: >-
FaNaC provides a fast excitatory mechanism for FMRFamide signaling,
complementing slower GPCR-mediated modulation
- id: DOI:10.3389/fimmu.2022.825634
title: >-
Inhibitory Effect of FMRFamide on NO Production During Immune Defense in
Sepiella japonica.
findings:
- statement: >-
FMRFamide has an immunoregulatory role: knockdown of FMRFa causes excessive
NO production after immune challenge, while exogenous FMRFamide suppresses
NO levels
- statement: >-
FMRFa gene expression upregulated alongside NOS expression during bacterial
infection, suggesting neuroimmune feedback regulation
- statement: >-
FMRFamide-like peptides are present in venous blood of cephalopods, indicating
neurohormonal release into circulation
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
core_functions:
- molecular_function:
id: GO:0160041
label: neuropeptide activity
description: >-
The primary molecular function of FMRFa gene products is neuropeptide receptor ligand activity.
The precursor protein is proteolytically processed into multiple bioactive peptides (11 copies
of FMRFamide plus FIRF-amide, FLRF-amide, and ALSGDAFLRF-amide) that function as excitatory
neurotransmitters at the chromatophore neuromuscular junction. These peptides bind receptors
on chromatophore muscles to cause muscle contraction and chromatophore expansion. FaRPs serve
as the slow neurotransmitter component alongside glutamate (the fast component) mediating
neural control of chromatophore organs for body patterning in cuttlefish. Beyond chromatophore
control, the different FaRP variants have distinct effects on reproductive tissues: FMRFamide
and FLRFamide strongly stimulate oviduct contraction for egg transport, while FIRFamide and
ALSGDAFLRFamide reduce contraction frequency and tone, suggesting fine-tuned coordination
of egg-laying (Henry et al. 1999). FMRFamide also modulates nidamental gland contractions
for egg capsule secretion. FaRPs signal through two receptor types: GPCRs (triggering
second messenger cascades) and FMRFamide-gated Na+ channels (FaNaCs, providing fast
excitatory depolarization). Additionally, FMRFamide has been shown to function as a
negative feedback regulator of immune inflammation, inhibiting NO production during
immune defense in cephalopods.
directly_involved_in:
- id: GO:0007218
label: neuropeptide signaling pathway
- id: GO:0007268
label: chemical synaptic transmission
- id: GO:0045933
label: positive regulation of muscle contraction
locations:
- id: GO:0005576
label: extracellular region
supported_by:
- reference_id: PMID:10805923
supporting_text: >-
We conclude that glutamate and FaRPs likely function as fast and slow transmitters,
respectively, at the Sepia chromatophore NMJ.
- reference_id: PMID:9192498
supporting_text: >-
Each of the four FaRPs encoded by this cDNA causes chromatophore expansion when assayed
in an in vitro chromatophore bioassay.
suggested_questions:
- question: >-
What are the specific receptors for FMRFamide peptides on Sepia chromatophore muscles?
Identifying the receptor(s) would enable more precise annotation of the signaling pathway
and could clarify whether FMRFamide acts via ionotropic or metabotropic mechanisms.
- question: >-
Do different FaRP variants (FMRF vs FLRF vs FIRF vs ALSGDAFLRF) have distinct potencies
or receptor specificities at the chromatophore NMJ? The precursor encodes 14 peptides of
different sequences, suggesting possible functional diversification.
- question: >-
Are there other functional roles for FMRFa gene products beyond chromatophore regulation
(e.g., cardiovascular, feeding, reproductive functions)? The broad CNS expression pattern
of the related SOFaRP2 gene suggests possible pleiotropic functions.
- question: >-
What is the relationship between the two S. officinalis FaRP genes (FMRFa/SOFaRP1 and
SOFaRP2) in terms of functional redundancy or specialization at the chromatophore NMJ?
suggested_experiments:
- description: >-
Dose-response curves comparing the four FaRP variants (FMRFamide, FLRFamide, FIRFamide,
ALSGDAFLRFamide) for chromatophore expansion potency in the in vitro bioassay, to determine
whether different peptides from the same precursor have distinct efficacies.
hypothesis: >-
Different FaRP variants encoded by the same precursor may have distinct potencies at the
chromatophore NMJ, reflecting functional specialization within the peptide family.
- description: >-
In vivo gene knockdown (e.g., morpholino injection into embryos) of FMRFa to assess effects
on body patterning behavior and chromatophore function in developing cuttlefish.
hypothesis: >-
Loss of FMRFa expression will impair chromatophore-mediated body patterning behavior,
confirming the essential role of FaRPs in this process.
- description: >-
Electrophysiological recording of chromatophore muscle responses to individual FaRP peptides
to characterize the receptor pharmacology and ion channel mechanisms underlying FMRFamide
excitation at the chromatophore NMJ.
hypothesis: >-
FMRFamide peptides activate specific receptors on chromatophore muscles that produce slow
depolarizing currents, distinct from the fast glutamate-mediated response.